Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar SorrySam (73.24) Submitted: 3/19/2011 12:23:22 AM : Outperform Start Price: $9.45 LGND Score: +34.06

insider buying

Featured Broker Partners


Advertisement